₹20/- For Intraday, F&O, Currencies & Commodities
Windlas Biotech Limited IPO
Windlas Biotech Limited is one of the market leaders in the pharmaceutical formulations CDMO space. The company has a diverse product line-up and an impressive client base.
The platform offers a variety of learning courses to students of classes I - XII. In addition, Byju's also offers online courses to aspirants of competitive and entrance examinations. Accordingly, Byju’s has occupied a large market share and emerged as one of the pioneers in online education over the years.
Windlas Biotech Limited IPO Objectives
- Purchase equipment that will help to expand the company’s Dehradun Plant IV
- Fund incremental working capital needs
- Pre-payment and/or repayment of the company's borrowings
- Address general corporate purposes
Windlas Biotech Limited IPO - Details
This upcoming IPO will comprise new issues worth Rs. 165 crores and offer for sale (OFS) of 5.14 million shares. Here are other vital IPO details.
Opening Date
To be updated
Closing Date
To be updated
Price Band
To be updated
per equity share
Issue Size
₹ To be updated
Face Value
₹ To be updated
per equity share
Market Lot
To be updated
Opening Date
To be updated
Closing Date
To be updated
Price Band
To be updated
per equity share
Issue Size
₹ To be updated
Face Value
₹ To be updated
per equity share
Market Lot
To be updated
Listing at NSE, BSE
Windlas Biotech Limited IPO Important Dates
| IPO Open Date | 4 August 2021 |
|---|---|
| IPO Close Date | 6 August 2021 |
| Basis Of Allotment Date | 11 August 2021 |
| Initiation Of Refunds | 12 August 2021 |
| Credit Of Shares To Demat ACcount |
13 August 2021 |
| IPO Listing Date | 17 August 2021 |
| UPI Mandate Expiry Date | Yet to be announced |
How to apply for Windlas Biotech Limited IPO?
You can apply for the Windlas Biotech Limited IPO in these ways:
UPI
Link your bank account to a reliable UPI ID and register it with your Angel One account. Proceed to book Windlas Biotech Limited IPO shares using the ID, confirm the payment on the UPI app, and block the amount for allotment.
Demat Account
1. If you are already a client of Angel One, apply directly for Windlas Biotech Limited IPO, click here.
2. If you’re a new investor Open DEMAT Account for free with Angel One to begin your investment journey.
Windlas Biotech IPO – Company Highlights
Windlas Biotech Limited is one of the top 5 domestic pharmaceutical formulations CDMO companies in the country. The company has 4 active manufacturing facilities based in Uttarakhand. In addition, this company is proactive in selling products in the OTC and trade generics markets.
Other prominent highlights of Windlas Biotech include :
- It extends multiple CDMO services, including product discovery, product development, commercial manufacturing, and licensing.
- Windlas Biotech runs three business verticals, namely CDMO Products and Services, Domestic Trade Generics and Over-the-counter (OTC) market, and Export.
- Its clientele comprises reputed names such as Intas Pharmaceuticals, Sanofi India, Pfizer, and Cadila Healthcare.
- Windlas Biotech’s manufacturing facilities based in Dehradun have an operating capacity of nearly 7,063.83 million tablets/capsules, 61.08 million liquid (bottles), and 54.46 million sachets.
According to reports, the company is also planning to launch a complex generic products category.
Windlas Biotech Limited IPO - SWOT Analysis
Competitor Analysis: Market Peers
The last couple of years have witnessed a significant surge in demand for biologics and generic medicines. Accordingly, various new CDMO players have mushroomed in the market.
Some of the most popular CDMO companies and market peers of Windlas Biotech include Neuland Laboratories Ltd, Hikal Ltd, Suven Pharmaceuticals Ltd, Laurus Labs Ltd, and Jubilant Life Sciences Ltd.
However, one must note that the CDMO industry, in general, is very consolidated. Therefore, business opportunities in this space are mostly dependent on continued research and expenses to foster growth and expansion.
